Physician profile
Chaely Jones Medley
NPI 1477100832
$46,774.65
in general payments reported to CMS, 2019-2025
8 companies · $30K in 2025
The $30K reported for 2025 was more than what 99% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,974 · 2023: $14K · 2024: $26.61 · 2025: $30K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $21K · Honoraria: $9,720 · Travel and Lodging: $9,330 · Food and Beverage: $2,623 · Consulting Fee: $800 · Education: $77.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $21,249.84 |
| Honoraria | $9,720.00 |
| Travel and Lodging | $9,330.07 |
| Food and Beverage | $2,622.89 |
| Consulting Fee | $800.00 |
| Education | $77.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharmacosmos Therapeutics INC. | $26,524.66 | 2025 | Cosela, Monoferric |
| G1 Therapeutics, INC. | $17,049.41 | 2022-2023 | Cosela |
| Daiichi Sankyo INC. | $1,885.84 | 2024-2025 | Datroway, Enhertu |
| Catalyst Pharmaceuticals, INC. | $776.84 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $450.22 | 2025 | Imfinzi |
| Abbvie INC. | $47.23 | 2025 | |
| Iovance Biotherapeutics, INC. | $22.33 | 2025 | Amtagvi |
| Janssen Scientific Affairs, LLC | $18.12 | 2025 | Rybrevant |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chaely Medley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.